| Particulars |
|
|
|
| Company Name
| Cohance Lifesciences Ltd
| Year End
| 202603
|
| Full Year |
| Equity (₹ Cr.) |
38.26 |
B.V. (₹) |
117.10 |
| Sales(₹ Cr.) |
2,030.50 |
NP (₹ Cr.) |
250.20 |
| NP Var% |
-8.00 |
Div% |
0.00 |
| CPS(₹) |
10.00 |
EPS (₹) |
6.50 |
| Traded Value(₹ Lakhs) |
390.34 |
52 Week High |
1,121.00 |
| 52 Week Low |
268.00 |
Price BSE |
414.00 |
| Price NSE |
414.00 |
Market Capital (₹ Cr.) |
15,838.28 |
| P/C Ratio |
41.30 |
P/E Ratio |
63.30 |
| Price Vs.BV |
3.54 |
|
| Latest Quarter |
| Year End |
202603 |
Sales (₹ Cr.) |
567.55 |
| NP(₹ Cr.) |
44.67 |
NP Var % |
-67.00 |
| Trailing Twelve Months |
| Year End |
202603 |
Sales |
914.50 |
| OPM |
38.79 |
NP |
247.20 |
| NP Var% |
-7.94 |
EPS |
6.54 |
| PE |
63.30 |
|
|